Skip to site alert.
Skip to content
Make an Appointment
Our team is here to help you make an appointment with the specialists that you need.
Columbia Urology, in partnership with the National Cancer Institute-designated Herbert Irving Comprehensive Cancer Center, is one of the nation's premier urologic cancer treatment facilities. Our doctors develop and offer the newest medical therapies and surgical procedures for urologic cancers.
At Columbia Urology, we tailor cancer treatment for each of our patients based on the type and extent of their disease, which therapy promises the best chance of a cure, and how each treatment may affect quality of life.
Each of our doctors is internationally recognized in their respective fields. Columbia Urology surgeons are expert in the full spectrum of state-of-the-art surgical approaches to treating cancer and employ minimally invasive techniques whenever possible. We work closely with NewYork-Presbyterian oncologists and radiation oncologists to ensure that patients who are not eligible for surgery, who require a combination of therapies, or who opt for a different approach, receive optimal care.
Our physicians conduct research on the latest cancer treatments, including clinical trials on a range of novel and promising cancer treatments. Columbia Urology doctors often conduct research collaboratively with each other and with other departments. This provides a comprehensive and integrated research program designed to improve the accuracy of diagnosis and efficacy of treatment.
Bladder cancer is the second most common urologic cancer after prostate cancer.
Patients across the U.S. and worldwide seek the skills and technology offered by Columbia Urology's doctors.
The American Cancer Society estimates that about 1,200 new cases of penile cancer will be diagnosed in the United States this year, occurring in about 1 man out of 100,000.
At Columbia Urology, we are experienced at assessing the risks and determining a prognosis for each man's prostate cancer.
Testicular cancer is fairly rare, with just under 8,000 new cases a year in the United States. But this is among the most common cancers in young men.
Back to top